Evidence map›Paper›PMID 27649699›Full record

ArticleEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2017

Association between source control and mortality in 258 patients with intra-abdominal candidiasis: a retrospective multi-centric analysis comparing intensive care versus surgical wards in Spain.

L Lagunes, A Rey-Pérez, M T Martín-Gómez, A Vena, V de Egea, P Muñoz, E Bouza, A Díaz-Martín, I Palacios-García, J Garnacho-Montero and 3 more

Abstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 40 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Review on the management of intra-abdominal candidiasis.Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia · 2025
    Review
  5. Review
  6. Review
  7. Optimized Treatment of Nosocomial Peritonitis.Antibiotics (Basel, Switzerland) · 2023
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Detection ofFrontiers in microbiology · 2022
    Article
  13. Review
  14. Risk Factors for Mortality in Colombian Patients with Candidemia.Journal of fungi (Basel, Switzerland) · 2021
    Article
  15. Observational
  16. Quality of evidence supporting Surviving Sepsis Campaign Recommendations.Anaesthesia, critical care & pain medicine · 2020
    Article
  17. Article
  18. Impact of empirical treatment with antifungal agents on survival of patients with candidemia.Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia · 2019
    Article
  19. Changes in the epidemiological landscape of invasive candidiasis.The Journal of antimicrobial chemotherapy · 2018
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 2 countries.

L LagunesCritical Care Department, Vall d'Hebron University Hospital, Ps Vall d'Hebron 119-129, 08035, Barcelona, Spain. leonel.lagunes@gmail.com.
A Rey-PérezNeurocritical and Burns Intensive Care Department, Vall d'Hebron University Hospital, Barcelona, Spain.
M T Martín-GómezMicrobiology Department, Vall d'Hebron University Hospital, Barcelona, Spain.
A VenaMicrobiology and Infectious Diseases Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
V de EgeaMicrobiology and Infectious Diseases Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
P MuñozMicrobiology and Infectious Diseases Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
E BouzaMicrobiology and Infectious Diseases Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
A Díaz-MartínCritical Care Department, Virgen Rocío University Hospital, Sevilla, Spain.
I Palacios-GarcíaCritical Care Department, Virgen Rocío University Hospital, Sevilla, Spain.
J Garnacho-MonteroCritical Care Department, Virgen Rocío University Hospital, Sevilla, Spain.
M CampinsPreventive Medicine and Epidemiology Department, Vall d'Hebron University Hospital, Barcelona, Spain.
M BassettiIAC Study Coordinator, Infectious Diseases Division, Santa Maria Misericordia University Hospital, Udine, Italy.
J RelloMedicine Department, Universitat Autónoma de Barcelona, (UAB), Barcelona, Spain.
Vall d'Hebron Hospital Universitari · ESHospital General Universitario Gregorio Marañón · ESHospital Universitario Virgen del Rocío · ESOspedale Santa Maria della Misericordia di Udine · ITUniversidad Complutense de Madrid · ESUniversitat Autònoma de Barcelona · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Early empiric therapy and adequate resuscitation have been identified as main predictors of outcome in patients with candidemia or bacteremia. Moreover, source control is a major determinant in infectious sites when feasible, as a main technique to reduce microbiological burden. A retrospective, multicenter, cohort study was performed at surgical wards and intensive care units (ICU) of three University Hospitals in Spain between 2010 and 2014, with the aim of improving understanding of the interaction between source control, early antifungal therapy, and use of vasoactives in patients with intra-abdominal candidiasis (IAC). Source control was defined as all physical actions taken to control a focus of infection and reduce the favorable conditions that promote microorganism growth or that maintain the impairment of host defenses. Two hundred and fifty-eight patients with IAC were identified. Sixty-one patients were at ICU for diagnosis. Mortality was higher in the ICU group compared to what was documented for the non-ICU group (35 % vs 19.5 %, p = 0011). Adequate source control within 48 h of diagnosis was achieved in 60 % of the cohort. In multivariate analysis, inadequate source control was identified as the only common risk factor for 30-day mortality in both groups (ICU group OR: 13.78 (95% CI: 2.60-72.9, p = 0.002) and non-ICU group OR: 6.53 (95% CI: 2.56-16.61, p = <0.001). The population receiving both adequate source control and adequate antifungal treatment was the one associated with a higher survival rate, in both the ICU and surgical groups. Source control remains a key element in IAC, inside and outside the intensive care unit. Early antifungal treatment among ICU patients was associated with lower mortality.

Indexed as

AdultAgedAnimalsCandidiasisCritical CareFemaleHospitals, UniversityHumansIntraabdominal InfectionsMaleMiddle AgedPatient Care BundlesRetrospective StudiesSpainSurvival Analysis

Identifiers

PMID27649699
OpenAlexW2521554048

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.